Laser-assisted cryoEM method preserves protein structure
Combining mass spectrometry, or MS, and cryogenic electron microscopy, or cryoEM, has long promised high-resolution 3D reconstructions of proteins. Past attempts were limited by low resolution and protein compaction.
Keaton Mertz, Drew Jordahl and colleagues at the University of Wisconsin–Madison and the Morgridge Institute for Research developed a laser-assisted cryoEM method that overcomes these barriers, paving the way for broader MS–cryoEM integration. They published their findings in Molecular & Cellular Proteomics.
The method uses a laser built into transmission electron microscopy grids to liquefy ice particles. When the laser is turned off, proteins rehydrate and regain their native structure before refreezing, producing samples suitable for reconstruction.
Testing with β-galactosidase, the team showed that protein structure was restored without compaction. Results matched those from conventional plunge freezing but with fewer distortions. The researchers expect the technique will enable studies of more complex protein systems.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Method sharpens proteome-wide view of structural changes
Researchers developed a method that improves limited proteolysis coupled with mass spectrometry, separating true changes from abundance or splicing effects.
Discoveries made possible by DNA
The discovery of DNA’s double helix revealed how genetic information is stored, copied and expressed. Revisit that breakthrough and traces how it laid the foundation for modern molecular biology, genomics and biotechnology.
Unraveling the language of histones
Philip Cole presented his research on how posttranslational modifications to histones are involved in gene expression and how these modifications could be therapeutically targeted to treat diseases like cancer.
How Alixorexton could transform narcolepsy treatment
A new investigational drug, alixorexton, targets the brain’s orexin system to restore wakefulness in people with narcolepsy type 1. Alkermes chemist Brian Raymer shares how molecular modeling turned a lab idea into a promising phase 3 therapy.
Phosphatases and pupils: A dual legacy
Yale professor Anton Bennett explores how protein tyrosine phosphatases shape disease, while building a legacy of mentorship that expands opportunity and fuels discovery in biochemistry and molecular biology.
Extracellular vesicles offer clues to cattle reproduction
Extracellular vesicles from pregnant cattle support embryo development better than laboratory models, highlighting their potential to improve reproductive efficiency in bovine embryo cultures. Read more about this recent MCP paper.